COMMUNIQUÉS West-GlobeNewswire

Atrion Corporation Declares Quarterly Cash Dividend

08/11/2017 - 18:41

ALLEN, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI ) today announced that its Board of Directors declared a quarterly cash dividend of $1.20 per share on the Company’s outstanding Common [...]

ZoomMed Announces the Closing of a $500,000 Financing Agreement

08/11/2017 - 18:19

BROSSARD, Quebec, Nov. 08, 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX-V: ZMD ) announces the closing of a $500,000 secured financing agreement with a private investor dealing at arm’s length with ZoomMed. The loan bears [...]

ZoomMed annonce la clôture d’un financement de 500,000 $

08/11/2017 - 18:19

BROSSARD, Quebec, 08 nov. 2017 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX CROISSANCE:ZMD) annonce la clôture d’un financement garanti au montant de 500 000 $ avec un investisseur privé traitant à distance avec ZoomMed. Le [...]

Spine Injury Solutions Schedules Interactive Conference Call to Present 3rd Quarter 2017 Financial Results, Provide Business Development Update

08/11/2017 - 18:08

HOUSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), a technology-driven, medical service, and healthcare solution company servicing the multi-billion dollar spine injury sector, through [...]

Genmab Announces Financial Results for the First Nine Months of 2017

08/11/2017 - 17:01

November 8, 2017; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2017 Highlights USD 871 million in net sales of DARZALEX ® (daratumumab); resulting in royalty income of DKK 707 [...]

Des héros du DT1 de FRDJ militent pour la couverture des pompes à insuline au Manitoba

08/11/2017 - 16:00

WINNIPEG, Manitoba, 08 nov. 2017 (GLOBE NEWSWIRE) -- La journée de défense d’intérêts 2017 au Manitoba est l’occasion de faire avancer la cause. Aujourd’hui, 10 héros du DT1 – des défenseurs qui vivent avec le diabète [...]

JDRF’s T1D Heroes Advocating for Insulin Pump Coverage in Manitoba

08/11/2017 - 16:00

WINNIPEG, Manitoba, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Manitoba Lobby Day 2017 is an opportunity to make a difference. Today, 10 T1D Heroes – advocates living with type 1 diabetes (T1D) – are at the Manitoba Legislative [...]

CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

08/11/2017 - 16:00

- Record Quarter for all Financial Performance Metrics - Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results LAS VEGAS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) ( [...]

TPP Healthcare Launches New Website to Provide Stronger Insight to the World of Cross-Border Trade

08/11/2017 - 15:45

NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- TPP Healthcare , a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www. [...]

RedHill Biopharma Prices Public Offering of its American Depositary Shares

08/11/2017 - 15:13

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 08, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Aquinox Pharmaceuticals Announces Third Quarter 2017 Financial Results

08/11/2017 - 15:05

VANCOUVER, British Columbia, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in [...]

Zealand Pharma: Interim report for the first nine months of 2017

08/11/2017 - 15:01

Company announcement - No. 50/2017 Interim report for the first nine months of 2017 Copenhagen, November 8, 2017 - Zealand Pharma A/S ("ZEAL") announces financial results and continued strong progress for its product [...]

Travelan Experiences Strong Q1 FY2018 Sales Growth

08/11/2017 - 15:00

Key Highlights: Significant growth of sales for Immuron’s over-the-counter supplement Travelan ® for Q1 2018 compared to Q1 2017 Travelan ® US experienced a 197% increase in sales compared to Q1 2017 Travelan ® [...]

Epilepsy Foundation and Actor Greg Grunberg Encourage Everyone to Talk About It for 470,000 Kids in the United States Living with Epilepsy

08/11/2017 - 15:00

LANDOVER, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- More people live with active epilepsy than ever before, according to recent data from the Centers for Disease Control and Prevention. During National Epilepsy Awareness [...]

Rexahn Pharmaceuticals Doses First Patient in a Phase IIa Clinical Trial of RX-3117 in Combination with Abraxane® in Patients Newly Diagnosed with Metastatic Pancreatic Cancer

08/11/2017 - 15:00

ROCKVILLE, Md., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE AMERICAN:RNN), today announced that it has dosed the first patient in a Phase IIa clinical study of RX-3117 in combination with [...]

Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

08/11/2017 - 15:00

WALTHAM, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

MEDITE Cancer Diagnostics Reports Appointments of New Chairman of the Board and Chief Executive Officer

08/11/2017 - 14:31

ORLANDO, Fla., Nov. 08, 2017 (GLOBE NEWSWIRE) -- MEDITE Cancer Diagnostics, Inc. (OTCQB:MDIT) (the “Company”), specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical [...]

Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine

08/11/2017 - 14:30

FREMONT, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

08/11/2017 - 14:30

RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]